Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tomer Dicker"'
Autor:
Hadas Ganer Herman, Alina Rechulski Keizman, Hadas Miremberg, Yossi Mizrachi, Tomer Dicker, Michal Levy, Letizia Schreiber, Michal Kovo
Publikováno v:
International Journal of Gynecology & Obstetrics. 159:825-832
To assess obstetric, perinatal, and placental histologic findings in small-for-gestational-age (SGA) neonates according to different growth charts.A retrospective cohort of singleton deliveries from 2008 to 2019 were divided into SGA neonates accordi
Autor:
Ettai Markovits, Tal Dankovich, Roman Gluskin, Ido Weiss, Amit Gutwillig, Tomer Dicker, Sun Dagan, Ron Elran, Becky Arbiv, Yuval Shachaf, Amit Bart, Assaf Debby, Nethanel Asher, Guy Ben-Betzalel, Ronnie Shapira-Frommer, Iris Barshack, Ori Zelichov
BackgroundMultiplex immunofluorescence (mIF) can provide invaluable insights into spatial biology and the complexities of the immune tumor microenvironment (iTME). However, existing analysis approaches are both laborious and highly user-dependent. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8ed514d0255bc3d33328ce2ceb4a105
https://doi.org/10.1101/2022.11.09.515776
https://doi.org/10.1101/2022.11.09.515776
Autor:
Ettai Markovits, Roman Gluskin, Tomer Dicker, Ido Weiss, Sun Dagan, Ron Elran, Amit Bart, Oleg Kuybeda, Becky Arbiv, Ori Zelichov
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
David Soong, Becky Arbiv, Ettai Markovits, Alon Groisman, Yuval Shachaf, Tomer Dicker, Yoni Yedidia, Hisham Hamadeh, Kate Sasser, Gali Golan, Brandon Higgs, Suzana Couto, Ori Zelichov
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Becky Arbiv, Tal Dankovich, Sun Dagan, Yuval Shachaf, Tomer Dicker, Ron Elran, Avi Laniado, Amit Bart, Ori Zelichov, Ettai Markovits
Publikováno v:
Cancer Research. 83:4316-4316
Background: Tertiary lymphoid structures (TLS) are organized aggregates of immune cells that develop in non-lymphoid tissues and are associated with better prognosis and immunotherapy response across cancer types. Multiple IHC stainings are required
Autor:
Anna Pokorska-Bocci, Sandrine Micallef, Mariola Dymkowska, Yuval Gabay, Roman Gluskin, Avi Laniado, Efrat Dicker Sagy, Amit Bart, Tomer Dicker, Ifat Rotbein, Albert Achtenberg, Ori Zelichov
Publikováno v:
Journal of Clinical Oncology. 40:e19565-e19565
e19565 Background: DLBCL is the most common type of Non-Hodgkin’s lymphoma, accounting for 30-40% of cases. Despite improvements in response and survival with standard of care treatment, up to 40% of patients have relapsed and/or refractory (R/R) d